These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17139599)

  • 1. [Pulmonary arterial hypertension following pulmonary thromboembolism].
    Wilkens H
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S328-9. PubMed ID: 17139599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy.
    Hill NS; Preston IR; Roberts KE
    Chest; 2008 Aug; 134(2):221-223. PubMed ID: 18682450
    [No Abstract]   [Full Text] [Related]  

  • 3. "Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation.
    Hoeper MM
    Eur Respir Rev; 2011 Dec; 20(122):297-300. PubMed ID: 22130824
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of severe pulmonary hypertension secondary to scleroderma: a three-drug approach.
    Catapano-Minotti G; Corsonello A; Guadalupi G; Spani R; Antonelli-Incalzi R
    Intern Med; 2008; 47(6):511-3. PubMed ID: 18344637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug combination treatment for pulmonary arterial hypertension].
    Ghofrani HA; Hoeper MM
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S330-3. PubMed ID: 17139600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bosentan and chronic thromboembolic pulmonary hypertension].
    Tomás C; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
    Med Clin (Barc); 2007 Nov; 129(16):639. PubMed ID: 18001681
    [No Abstract]   [Full Text] [Related]  

  • 8. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
    Cannon JE; Pepke-Zaba J
    Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy in patients with pulmonary arterial hypertension].
    Ewert R; Opitz CF; Schäper C; Gläser S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S187-90. PubMed ID: 18814093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
    Hoeper MM
    Eur Respir J; 2007 Mar; 29(3):432-4. PubMed ID: 17329488
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
    Cotrim C; Loureiro MJ; Miranda R; Almeida S; Almeida AR; Simões O; Cordeiro P; Carrageta M
    Cardiovasc Ultrasound; 2007 Dec; 5():50. PubMed ID: 18162132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary arterial hypertension: combination therapy in the modern management era.
    Sitbon O
    Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved survival in patients with inoperable chronic thromboembolic pulmonary hypertension.
    Marini C; Formichi B; Bauleo C; Michelassi C; Prediletto R; Catapano G; Genovesi D; Monti S; Mannucci F; Giuntini C
    Intern Emerg Med; 2013 Jun; 8(4):307-16. PubMed ID: 21553238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination drug therapy in the management of pulmonary arterial hypertension.
    Kayser SR
    Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-associated pulmonary hypertension: diagnosis and treatment.
    Burkart KM; Farber HW
    Adv Cardiol; 2003; 40():197-207. PubMed ID: 14533555
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension.
    He B; Zhang F; Li X; Tang C; Lin G; Du J; Jin H
    Circ J; 2010 Jul; 74(7):1458-64. PubMed ID: 20519876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
    Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
    Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan for the treatment of portopulmonary hypertension.
    Tempe DK; Datt V; Datta D
    Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.